PATENT CLAIM ANALYSIS

Application Number: 15885267
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure relates to a vaccine composition, wherein the vaccine composition comprises an immune amount of fowl adenovirus Fiber-2 protein or an immune amount of a live vector recombined with gene of the fowl adenovirus Fiber-2 protein, and a pharmaceutically acceptable carrier. The vaccine composition can provide effective immune protection against different serotypes of adenoviruses and provide a protection rate of 100% at low levels of immunogenic components, showing good immunological efficacy.

Claim (Index 11):
The vaccine composition according to  claim 10 , wherein the other antigens comprises inactivated antigen of Newcastle disease virus, inactivated antigen of avian influenza virus, VP2 protein of avian infectious bronchitis virus antigen, inactivated antigen of infectious bursal disease virus, and inactivated antigen of egg drop syndrome virus.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.54902
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10429735', '14020024', '14682798', '10377718', '14747419']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7689042021666284
- 35 USC 102 Novelty (BERT): 0.5195795631926883
- Combined Prediction Score: 0.7439717382692344
- Mean Citation Score: 292.112548
- Max Citation Score: 312.93018
- Similarity Product: 219.17887044918533

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test